Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Invesco Ltd: Form 8.3 - QUALCOMM Inc; Public dealing disclosure
-
Form 8.3 - Advanced Medical Solutions Group Plc - Octopus Investments
-
Iveco Group announces the results of the Annual General Meeting
-
Barça Mobile: A New Era of Connectivity for Barça Supporters
-
Resolutions of the annual general meeting of shareholders of Coop Pank AS
-
South Bow Safely Restarts Keystone Pipeline
-
BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer
-
American Tungsten Corp. Applauds U.S. Presidential Executive Order to Ensure National Security Through the Assessment of and Securing of Domestic Critical Minerals Supply Chains
-
Avicanna Announces Revocation of Management Cease Trade Order
-
Geomega and Rio Tinto provide update on bauxite residue valorization pilot
-
Garrett Motion to Hold First Quarter 2025 Financial Results Conference Call on Thursday May 01, 2025
-
LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation
-
NextGen Digital Reiterates Its Strategic Plan to Build Significant Long-Term Value
-
Purpose Investments Debuts World’s First Spot Solana ETF That Will Be Staked – Continuing Its Leadership in Global Crypto Innovation
-
Paladin to Defend Class Action
-
Draganfly Establishes Public Safety Advisory Board, Appoints Homeland Security and Law Enforcement Expert Paul Goldenberg as Chair
-
UAB „Atsinaujinančios energetikos investicijos“ publishes audited consolidated and separate annual financial statements for 2024
-
IREN capacity increased to 40 EH/s
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 15 04 2025] - (CGAML)
-
Pilot John International Adds New Aviation Products to its E-Commerce Shop
-
Awilco Drilling PLC: De-listing Application sent to Oslo Børs
-
MADD Canada Calls for Safe Choices to Prevent Impaired Driving This Easter Long Weekend
-
ISC Addresses Plantro Misstatements and Reconfirms Recommendation to Reject Plantro Mini-Tender
-
XPENG Files 2024 Annual Report on Form 20-F
-
Rogers Communications Inc. Announces Successful Completion of Consent Solicitations for Senior Notes to Facilitate Subsidiary Equity Investment
-
Purple Biotech Announces Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer
-
Morning After Federal Election, Canada’s Top Innovation Leaders Converge at NACO Summit in Ottawa
-
Mx2 Mining Completes Transaction with Aya Gold & Silver
-
Spectral Medical Completes Tigris Trial Enrollment
-
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream
-
Aya Gold & Silver Announces Completion of Strategic Transaction with Mx2 Mining
-
Special Needs Network Hosts 19th Annual Tools for Transformation Conference
-
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025
-
U.S. Energy Corp. Announces Acreage Acquisition and CCUS Development Update
-
Purple Biotech Announces Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer
-
The College of Commercial Arbitrators Reaffirms Commitment to the Rule of Law
-
Rivalry Reports Strong Q1 2025 KPI Growth, Validating Strategic Pivot Amid Temporary Margin Variance
-
Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
-
INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology
-
UgoWork strengthens its industry presence through a packed spring 2025 industry calendar
-
Tilray Brands Ranks #4 on the Brewers Association List of Top Producing Craft Brewers in the United States
-
OTC Markets Group Welcomes Sprott Physical Copper Trust to OTCQX
-
Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid A
-
AIR Education Experts Share Evidence at American Educational Research Association, National Council on Measurement in Education Annual Meetings
-
AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer Screening Trial to Expedite MSC Commercialization Plan
-
FXDyno's AI-Powered Wave Trading Set to Redefine Gold Trading
-
FXDyno's AI-Powered Wave Trading Set to Redefine Gold Trading
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 15 04 2025] - (CGWL)

